These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 124806)

  • 1. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis associated antigen (HAA) in an institution for the mentally retarded.
    Chance ER
    Am J Ment Defic; 1972 Jul; 77(1):1-5. PubMed ID: 4262234
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis-B surface antigen among residents of an institution for the mentally retarded.
    Bruhl HH; Bauer H; Levy BS; Siem RA
    Minn Med; 1976 Apr; 59(4):263-7. PubMed ID: 131906
    [No Abstract]   [Full Text] [Related]  

  • 8. HBsAg and anti-HBs in staff and patients of a psychopaedic hospital.
    Faoagali JL; Young SA
    N Z Med J; 1977 May; 85(588):416-20. PubMed ID: 146172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anti-HBs in two groups of institutionalized people by solid-phase radioimmunoassay using human labelled antibody.
    Schiano G; Franco E; Schipilliti G; Ricci G
    Dev Biol Stand; 1975; 30():116-9. PubMed ID: 1204949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in Down's syndrome. I. Genetic predisposition to become a carrier of the Au-SH antigen?
    Rittner C; Schwinger E; Stockhausen FG; Dufkova J
    Vox Sang; 1970; 19(3):280-7. PubMed ID: 4251110
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination.
    Tsuda F; Takahashi T; Takahashi K; Miyakawa Y; Mayumi M
    J Immunol; 1975 Sep; 115(3):834-8. PubMed ID: 1171142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core antibodies and other parameters of hepatitis B virus infection in a tropical population.
    Desmyter J; Bradburne AF
    Dev Biol Stand; 1975; 30():194-200. PubMed ID: 1204958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sex difference in the carrier state of Australia (hepatitis-associated) antigen.
    Goodman M; Wainright RL; Weir HF; Gall JC
    Pediatrics; 1971 Dec; 48(6):907-13. PubMed ID: 4256915
    [No Abstract]   [Full Text] [Related]  

  • 17. New immunologic relationships of Australia antigen.
    Sutnick AI; Raunio VK; London WT; Millman I; Blumberg BS
    Vox Sang; 1970; 19(3):296-303. PubMed ID: 4100646
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australia antigen, autoantibodies and cell-mediated immune responses in patients with Down's syndrome.
    Campion EC; Wangel AG
    Med J Aust; 1975 Apr; 01(15):468-70. PubMed ID: 125374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.